Skip to main content
. 2018 May 14;89(4):399–405. doi: 10.1080/17453674.2018.1473327

Table 2.

Sample characteristics by diabetic status at preoperative assessment. Values are number (percentage) unless otherwise stated

  Total
sample
Nondiabetic
patients
Diabetic
patients
  n = 587 n = 523 n = 64
Trial intervention
 Injection 294 (50) 263 (50) 31 (48)
 Standard care 293 (50) 260 (50) 33 (52)
Primary total joint replacement
 Hip 300 (51) 276 (53) 24 (37)
 Knee 287 (49) 247 (47) 40 (63)
Age, mean (SD) 68 (10) 68 (10) 70 (8)
Sex
 Female 325 (55) 295 (56) 30 (47)
 Male 262 (45) 228 (44) 34 (53)
BMI, mean (SD) 31 (6) 31 (6) 34 (6)
 ≤ 30 303 (52) 282 (54) 21 (33)
 > 30 284 (48) 241 (46) 43 (67)
EQ VASa, n 553 492 61
 mean (SD) 66 (20) 66 (20) 64 (19)
EQ-5D Scoreb, n 555 495 60
 mean (SD) 0.42 (0.32) 0.43 (0.32) 0.37 (0.31)
FCIc (Number of comorbidities)
192 (33) 178 (34) 14 (22)
 2 168 (29) 156 (30) 12 (19)
 3 115 (20) 102 (19) 13 (20)
112 (19) 87 (17) 25 (39)
HADSd Total, n 567 505 62
 mean (SD) 13 (7) 13 (7) 13 (6)
WOMACe Pain, n 587 523 64
 mean (SD) 42 (17) 43 (18) 41 (15)
WOMAC Function, n 558 499 59
 mean (SD) 44 (18) 44 (18) 43 (16)
WOMAC Stiffness, n 548 487 61
 mean (SD) 44 (22) 43 (22) 44 (18)
WOMAC Total, n 537 479 58
 mean (SD) 44 (17) 44 (17) 44 (14)
a

EQ visual analogue scale (0–100, worst to best health state).

b

EQ-5D 3L descriptive system.

c

Modified Functional Co-morbidity Index without BMI and diabetes diagnoses (categorized sum of the 16 remaining diagnoses).

d

Hospital Anxiety and Depression Scale with anxiety and depression scores combined (0–42, best to worst distress state).

e

Western Ontario and McMaster Universities Osteoarthritis Index (0–100 worst to best pain, function, stiffness or total score).